KRAS Mutation in Lung Cancer: Molecular Testing, Targeted Therapy and NSCLC Treatment Options

Discover Lung Cancer and KRAS Mutations: What Patients Need to Know with a focused overview of non-small cell lung cancer treatment, NSCLC biomarker testing, and EGFR ALK ROS1 KRAS testing. The video outlines PD-L1 immunotherapy, lung cancer staging, and thoracic oncology, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for non-small cell lung cancer treatment, PD-L1 immunotherapy, or lung cancer staging and wanting a clearer explanation of how oncologists make treatment decisions. Relevant for anyone seeking clear, evidence-based context before discussing options with a multidisciplinary cancer team. Modern oncology